Revenue ($USD) : $1,707,197,000
R&D spend : $75,331,000
Employees : 6,550
Fiscal year end : 12/31/2023
CEO : Matthew Trerotola

www.enovis.com

Enovis — the world’s sixth-largest orthopedic device company and parent company of the DJO brand — is getting larger as it integrates LimaCorporate and its patient-tailored, 3D-printed titanium implants for complex reconstructive surgeries. Enovis completed the $846 million acquisition in January 2024. Enovis is kicking off a multiyear cadence of new product introductions across its two business segments: Prevention and Recovery (P&R) and Recon. –CN

MORE ON MDO: 5 titanium 3D printing questions with Riccardo Toninato at Enovis